Aberrations of the number of copies (CNA) in the genome of luminal B breast tumor

by M. K. Ibragimova, M. M. Tsyganov, E. M. Slonimskaya, N. V. Litviakov
Published 2020-10-01

LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER

by M. M. Tsyganov, M. K. Ibragimova, A. M. Pevzner, N. V. Litviakov
Published 2020-07-01

Human papillomavirus in head and neck cancer (literature review)

by A. M. Pevzner, M. M. Tsyganov, M. K. Ibragimova, N. V. Litvyakov
Published 2019-07-01

PARP1 inhibitors in breast cancer therapy. Mechanism of action and clinical use

by D. S. Dolgasheva, A. M. Pevzner, M. K. Ibragimova, N. V. Litvyakov, M. M. Tsyganov
Published 2020-06-01

SINGLE NUCLEOTIDE POLYMORPHISMS IN BREAST TUMOR AND EXPRESSION OF ABC-TRANSPORTERS AFTER NEOADJUVANT CHEMOTHERAPY

by M. M. Tsyganov, M. K. Ibragimova, E. M. Slonimskaya, N. V. Cherdyntseva, N. V. Litviakov
Published 2016-02-01

Assessing survival rate of HPV-positive and HPV-negative cervical cancer patients

by M. K. Ibragimova, M. M. Tsyganov, O. N. Churuksaeva, L. A. Kolomiets, N. V. Litviakov
Published 2019-11-01

The prognostic significance of BRCA1 gene expression in patients with breast cancer

by M. M. Tsyganov, M. K. Ibragimova, A. M. Pevzner, E. Yu. Garbukov, E. M. Slonimskaya, N. V. Litviakov
Published 2019-07-01

BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer

by M. M. Tsyganov, M. K. Ibragimova, I. V. Deryusheva, P. V. Kazantseva, E. Yu. Garbukov, E. M. Slonimskaya, N. V. Litviakov
Published 2018-05-01

Effects of achilline on lipid metabolism gene expression in cell culture

by A. V. Ratkin, Iu. A. Pfarger, O. A. Kaidash, V. V. Ivanov, M. M. Tsyganov, V. S. Chuchalin, S. M. Adekenov, V. V. Novitsky
Published 2016-10-01

STUDY OF THE HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS PHYSICAL STATUS IN PATIENS WITH NON-SMALL CELL LUNG CANCER

by M. K. Ibragimova, M. M. Tsyganov, A. M. Pevzner, E. O. Rodionov, O. V. Cheremisina, S. V. Miller, S. A. Tuzikov, N. V. Litviakov
Published 2021-05-01

A PERSONALIZED APPROACH TO ADJUVANT CHEMOTHERAPY FOR NON-SMALL CELL LUNG CANCER AFTER RADICAL SURGICAL TREATMENT BASED ON MOLECULAR MARKERS OF CHEMOSENSITIVITY

by L. A. Efteev, E. O. Rodionov, S. V. Miller, S. A. Tuzikov, M. M. Tsyganov, I. V. Deryusheva, N. V. Litvyakov, I. G. Frolova
Published 2019-11-01

Gene expression analysis of ABC transporter family in breast tumors: relationship with chemotherapy effect and disease prognosis

by M. M. Tsyganov, M. K. Ibragimova, A. M. Pevzner, K. A. Gaptulbarova, E. Yu. Garbukov, Е. М. Slonimskaya, E. A. Usynin, N. V. Litviakov
Published 2020-09-01

The clinical observation of human papillomavirus positive breast tumor

by M. K. Ibragimova, M. M. Tsyganov, N. A. Tarabanovskaya, L. A. Tashireva, I. V. Deryusheva, V. M. Perelmuter, E. M. Slonimskaya, N. V. Litviakov
Published 2018-03-01

Phenomenon of loss of heterozygosity in tumour tissue of breast cancer: association with expression of monoresistance genes

by M. M. Tsyganov, I. V. Deryusheva, E. Yu. Garbukov, M. K. Ibragimova, P. V. Kazantseva, V. A. Bychkov, E. M. Slonimskaya, N. V. Litviakov
Published 2018-01-01

RESPONSE TO NEOADYAVANT CHEMOTHERAPY WITH PLATINUM-BASED DRUGS IN BREAST CANCER PATIENTS WITH BRCA1 DELETION IN TUMOR

by M. M. Tsyganov, N. A. Tarabanovskaya, I. V. Deryusheva, M. K. Ibragimova, P. V. Kazantseva, A. M. Pevzner, E. M. Slonimskaya, N. V. Litviakov
Published 2019-06-01

Physical status of human papillomavirus in the prognosis of recurrence of low-grade and-high-grade cervical intraepithelial lesions

by M. K. Ibragimova, O. N. Churuksaeva, V. A. Bychkov, M. M. Tsyganov, I. V. Deryusheva, O. V. Shpileva, L. A. Kolomiets, N. V. Litviakov
Published 2019-01-01

ASSOCIATION OF THE COMBINATION OF STEMNESS GENE AMPLIFICATIONS AND COPY NUMBER ABERRATIONS OF WNT-SIGNALING GENES IN BREAST TUMORS WITH METASTASIS

by N. V. Litviakov, M. K. Ibragimova, M. M. Tsyganov, I. V. Deriusheva, A. M. Pevsner, E. Yu. Garbukov, A. V. Doroshenko, E. M. Slonimskaya
Published 2020-07-01

ROLE OF TRANSFORMING GROWTH FACTOR RECEPTOR B I TYPE (TGF-BRI) IN THE PROGRESSION OF THE LUMINAL BREAST CANCER SUBTYPE

by N. N. Babyshkina, S. V. Vtorushin, T. A. Dronova, N. V. Krakhmal, M. V. Zavyalova, M. M. Tsyganov, S. V. Patalyak, E. M. Slonimskaya, N. V. Cherdyntseva
Published 2017-06-01

PERSONALIZED APROACH TO POSTOPERATIVE CHEMOTHERAPY IN THE COMBINED MODALITY TREATMENT OF NON-SMALL CELL LUNG CANCER (CLINICAL CASE)

by E. O. Rodionov, S. V. Miller, M. M. Tsyganov, O. V. Cheremisina, S. A. Tuzikov, N. V. Litvyakov, I. G. Frolova, S. A. Velichko, P. I. Lukyanenok, T. V. Polishchuk
Published 2016-07-01

mRNA expression of chemosensitivity genes as a predictor of response to neoadjuvant chemotherapy in non-small cell lung cancer

by M. M. Tsyganov, I. V. Deryusheva, E. O. Rodionov, L. A. Efteev, S. V. Miller, M. K. Ibragimova, E. E. Perminova, O. V. Cheremisina, I. G. Frolova, S. A. Tuzikov, N. V. Litviakov
Published 2019-02-01